Postoperative radiation performed at the same surgical facility associated with improved overall survival in oral cavity squamous cell carcinoma.


Journal

Head & neck
ISSN: 1097-0347
Titre abrégé: Head Neck
Pays: United States
ID NLM: 8902541

Informations de publication

Date de publication:
07 2019
Historique:
received: 27 02 2018
revised: 10 12 2018
accepted: 24 01 2019
pubmed: 10 2 2019
medline: 18 11 2020
entrez: 10 2 2019
Statut: ppublish

Résumé

The purpose of this analysis is to evaluate whether postoperative radiotherapy (PORT) at the same facility as surgery portends to better survival outcomes compared to PORT given at a different facility. Patients underwent upfront surgery at the National Cancer Database reporting facility followed by PORT. PORT was coded as performed at either the same facility or at a different facility as surgery. A total of 10 832 patients were selected. Five-year overall survival (OS) was higher in patients undergoing PORT at the same facility: 52.5% vs 48.4% (P < 0.001). PORT performed at the same facility was associated with improved OS under multivariate (HR, 0.92; P = 0.01) and propensity score matched (hazard ratio, 0.90; P = 0.004) analyses. OS was better among patients with head and neck cancer who received PORT at the same facility as surgery.

Sections du résumé

BACKGROUND
The purpose of this analysis is to evaluate whether postoperative radiotherapy (PORT) at the same facility as surgery portends to better survival outcomes compared to PORT given at a different facility.
METHODS
Patients underwent upfront surgery at the National Cancer Database reporting facility followed by PORT. PORT was coded as performed at either the same facility or at a different facility as surgery.
RESULTS
A total of 10 832 patients were selected. Five-year overall survival (OS) was higher in patients undergoing PORT at the same facility: 52.5% vs 48.4% (P < 0.001). PORT performed at the same facility was associated with improved OS under multivariate (HR, 0.92; P = 0.01) and propensity score matched (hazard ratio, 0.90; P = 0.004) analyses.
CONCLUSIONS
OS was better among patients with head and neck cancer who received PORT at the same facility as surgery.

Identifiants

pubmed: 30737961
doi: 10.1002/hed.25697
pmc: PMC6886367
mid: NIHMS1036939
doi:

Types de publication

Comparative Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2299-2308

Subventions

Organisme : NCI NIH HHS
ID : K12 CA086913
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA046934
Pays : United States

Informations de copyright

© 2019 Wiley Periodicals, Inc.

Références

Pharm Stat. 2011 Mar-Apr;10(2):150-61
pubmed: 20925139
J Clin Epidemiol. 1992 Jun;45(6):613-9
pubmed: 1607900
J Clin Oncol. 2016 Mar 1;34(7):684-90
pubmed: 26729432
J Clin Oncol. 2015 Jan 10;33(2):156-64
pubmed: 25488965
Cancer. 2017 Dec 15;123(24):4841-4850
pubmed: 28841234
Laryngoscope. 2014 Jul;124(7):1603-8
pubmed: 24318221
J Natl Compr Canc Netw. 2017 Jun;15(6):761-770
pubmed: 28596256
Cancer. 2013 May 15;119(10):1845-52
pubmed: 23456789
Cancer. 2010 Oct 15;116(20):4744-52
pubmed: 20589761

Auteurs

Arya Amini (A)

Department of Radiation Oncology, City of Hope National Cancer Center, Duarte, California.
Department of Radiation Oncology, University of Colorado School of Medicine, Aurora, Colorado.

William A Stokes (WA)

Department of Radiation Oncology, City of Hope National Cancer Center, Duarte, California.

Bernard L Jones (BL)

Department of Radiation Oncology, City of Hope National Cancer Center, Duarte, California.

Sagus Sampath (S)

Department of Radiation Oncology, City of Hope National Cancer Center, Duarte, California.

Robert S Kang (RS)

Division of Head and Neck Surgery, City of Hope National Cancer Center, Duarte, California.

Thomas J Gernon (TJ)

Division of Head and Neck Surgery, City of Hope National Cancer Center, Duarte, California.

Ellie G Maghami (EG)

Division of Head and Neck Surgery, City of Hope National Cancer Center, Duarte, California.

Erminia Massarelli (E)

Department of Medical Oncology & Therapeutics Research, City of Hope National Cancer Center, Duarte, California.

Cathy J Bradley (CJ)

Department of Health Systems Management and Policy, Colorado Comprehensive Cancer Center, University of Colorado, Aurora, Colorado.

Sana D Karam (SD)

Department of Radiation Oncology, University of Colorado School of Medicine, Aurora, Colorado.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH